Home > National Drug Code (NDC) > LEADER TRIPLE ANTIBIOTIC

LEADER TRIPLE ANTIBIOTIC - 37205-273-10 - (BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE)

Alphabetical Index


Drug Information of LEADER TRIPLE ANTIBIOTIC

Product NDC: 37205-273
Proprietary Name: LEADER TRIPLE ANTIBIOTIC
Non Proprietary Name: BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE
Active Ingredient(s): 400; 3.5; 5000    [iU]/g; mg/g; [iU]/g & nbsp;   BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE
Administration Route(s): TOPICAL
Dosage Form(s): OINTMENT
Coding System: National Drug Codes(NDC)

Labeler Information of LEADER TRIPLE ANTIBIOTIC

Product NDC: 37205-273
Labeler Name: CARDINAL HEALTH
Product Type: HUMAN OTC DRUG
FDA Application Number: part333B
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20120301

Package Information of LEADER TRIPLE ANTIBIOTIC

Package NDC: 37205-273-10
Package Description: 1 TUBE in 1 CARTON (37205-273-10) > 28 g in 1 TUBE

NDC Information of LEADER TRIPLE ANTIBIOTIC

NDC Code 37205-273-10
Proprietary Name LEADER TRIPLE ANTIBIOTIC
Package Description 1 TUBE in 1 CARTON (37205-273-10) > 28 g in 1 TUBE
Product NDC 37205-273
Product Type Name HUMAN OTC DRUG
Non Proprietary Name BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE
Dosage Form Name OINTMENT
Route Name TOPICAL
Start Marketing Date 20120301
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name CARDINAL HEALTH
Substance Name BACITRACIN; NEOMYCIN; POLYMYXIN B SULFATE
Strength Number 400; 3.5; 5000
Strength Unit [iU]/g; mg/g; [iU]/g
Pharmaceutical Classes

Complete Information of LEADER TRIPLE ANTIBIOTIC


General Information